WeVote

Bill

Bill

SB 3550

CD CORR-LONG-ACTING INJECT MED

104th Regular Session Introduced by Napoleon Harris and 1 co-sponsor

Illinois bill establishing policies for long-acting injectable medications in correctional facilities, affecting inmate healthcare access and treatment protocols.

0
WeVote Research Nonpartisan
Bill Summary · SB 3550

Legislative bill overview

SB 3550 appears to address correctional department policies regarding long-acting injectable medications. Based on the bill title referencing "CD CORR" (Correctional Department) and "LONG-ACTING INJECT MED," this legislation likely establishes protocols, access, or oversight for administering extended-release pharmaceutical treatments within Illinois correctional facilities. The bill is in early stages, having just completed first reading and committee assignment.

Why is this important

Long-acting injectable medications in correctional settings raise significant public health and criminal justice concerns. These medications—commonly used for mental health conditions, substance use disorders, and chronic illnesses—can improve health outcomes and reduce institutional disruptions, but their administration in custodial settings involves questions about consent, medical autonomy, and treatment access for incarcerated populations. This legislation could either expand access to beneficial treatments or establish guardrails around their use.

Potential points of contention

  • Medical autonomy and consent: Whether incarcerated individuals can refuse long-acting injectables and what procedures protect informed consent in a coercive institutional environment
  • Resource allocation: Costs of long-acting medications versus standard treatments, and whether budget constraints limit access for incarcerated populations
  • Treatment equity: Whether these medications are administered consistently across racial, gender, and security-level populations, or whether disparities exist

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.